COVID-19 Clinical Trials

Showing 1061-1080 of 1,603 trials

Risk Factors for Community- and Workplace Transmission of COVID-19

NCT04320732

The project is an epidemiological observational study based on an electronic questionnaire on risk factors for COVID-19 in the community and healthcare setting.

Coronavirus

Oslo University Hospital250,000 participantsStarted Mar 2020

Oslo, Norway

COMPLETEDNA

Video Messages and Vaccination Intention

NCT04979416

This study uses an online panel survey to test the impact of video messages on stated likelihood of COVID-19 vaccination. Participants, who have self-identified as unvaccinated against COVID-19, are randomly assigned to either no video message or 1 of 3 video messages to encourage vaccine take-up. The key endpoint is a question about the likelihood of getting vaccinated in the next 30 days.

COVID-19 Vaccination

University of Southern California1,001 participantsStarted Jul 2021

Los Angeles, California, United States

COMPLETEDNA

Anti-Androgen Treatment for COVID-19

NCT04446429

This study is intended to explore the possible protective role of anti-androgens in SARS-CoV-2 infection

COVID-19SARS-CoV2Androgenetic Alopecia+3 more

Applied Biology, Inc.268 participantsStarted Oct 2020

Brasília, Brazil

COMPLETEDPhase 1

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

NCT05148754

An open-label clinical study of the pharmacokinetics and safety of Elsulfavirine, 200 mg tablets, with single and multiple oral administration in healthy volunteers.

Covid19HIV-1-infection

Viriom15 participantsStarted Jan 2021

Moscow, Russia

Risk Factors for Community- and Workplace Transmission of COVID-19

Video Messages and Vaccination Intention

Anti-Androgen Treatment for COVID-19

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Related Searches

Gut Microbiota, the Potential Key to Modulating Humoral Immunogenicity of New Platform COVID-19 Vaccines

MR-Evaluation of Renal Function In Septic Patients

Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease

Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients

Study of the Effect of Systematic Screening of Residents and Caregivers With Covid-19 by Nasopharyngeal Swab (RT-PCR)

YKL -40 as New Biomarker in COVID -19 Patients

Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19

Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2

Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children

Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients

The South Proxa-Rescue AndroCoV Trial Against COVID-19

Vitamin D Supplementation and Clinical Improvement in COVID-19

A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above

Newborns in Level III Services in Alsace From Mothers With COVID-19

A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19

Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen